US Pre-Market SEC Filings Roundup — January 12, 2026

13-01-2026

CompoSecure, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001104659-26-003019, Size: 961 KB), disclosing entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), completion of acquisition or disposition of assets (Item 2.01), creation of direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), changes in certifying accountant (Item 4.01), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles/bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific parties, deal structure, valuation, or quantitative details are disclosed in the provided filing summary. All key transaction metrics such as deal size, consideration, and synergies are NOT_DISCLOSED.

13-01-2026

Milestone Pharmaceuticals Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003038, size 190 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

UNITY BANCORP INC /NJ/ filed a Form 8-K on January 13, 2026 (AccNo: 0000920427-26-000004), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market with no specific quantitative metrics, transaction values, or detailed financial data provided in the filing summary. Sector is not specified.

13-01-2026

Bitcoin Depot Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011043, Size: 183 KB) reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote outcomes, or any numerical results are disclosed in the provided filing summary. This appears to be a mandatory single-item disclosure following a shareholder meeting.

13-01-2026

Offerpad Solutions Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011046, Size: 466 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts disclosed in the provided information.

13-01-2026

Resolute Holdings Management, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001104659-26-003021), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.01 completion of an acquisition or disposition of assets, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 4.01 changes in certifying accountant, and Item 9.01 financial statements and exhibits. No specific details on deal parties, structure, valuation, or quantitative metrics are provided in the filing summary. Sector is not specified.

13-01-2026

EBR Systems, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001214659-26-000377, Size: 238 KB) under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a financial results disclosure from the US market with sector not specified. No specific financial metrics, transaction values, or quantitative data are mentioned.

13-01-2026

D. Boral ARC Acquisition I Corp. filed an 8-K on January 13, 2026 (AccNo: 0001829126-26-000260, Size: 1 MB) disclosing a Merger/Acquisition event with Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Sector not specified. No specific details on parties, deal structure, valuation, or rationale provided in the summary.

13-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001931, Size: 221 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed. Sector is not specified.

13-01-2026

Figure Technology Solutions, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001929, size 206 KB) under Item 2.02 reporting Results of Operations and Financial Condition. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

USBC, Inc. disclosed an officer change via Form 8-K filed on January 13, 2026 (AccNo: 0001654954-26-000281, Size: 147 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data provided in the available information. Sector not specified.

13-01-2026

Inflection Point Acquisition Corp. III filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003622, Size: 52 MB) disclosing a Merger/Acquisition event under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Sector not specified. No specific details on parties, structure, valuation, or financial metrics are explicitly stated.

13-01-2026

Momentus Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001140361-26-001016, Size: 365 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.03 (Material Modifications to Rights of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, parties, dollar amounts, share counts, or other quantitative metrics are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Ashford Hospitality Trust Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001232582-26-000002, size 499 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with no sector specified. No core event details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary.

13-01-2026

BRC Inc. filed an 8-K on January 13, 2026 (AccNo: 0001891101-26-000002, Size: 5 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.

13-01-2026

This is a US SEC Form 8-K filing dated January 13, 2026 (AccNo: 0001213900-26-003572, Size: 198 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's name, position, reason for change, appointment/resignation status, or any quantitative data are provided. Sector is not specified.

13-01-2026

Bank of New York Mellon Corp filed an 8-K on January 13, 2026 (AccNo: 0001390777-26-000004, size: 8 MB) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned.

13-01-2026

Lafayette Digital Acquisition Corp. I filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003590), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing relates to a merger/acquisition event, but specific parties, deal structure, valuation, or quantitative details are NOT_DISCLOSED in the provided summary. Sector is not specified.

13-01-2026

CANNAPHARMARX, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001654954-26-000277, Size: 247 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

13-01-2026

News Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001564708-26-000008, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Delek US Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001886, Size: 3 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a general filing from the US SEC with sector not specified. No core event details, financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

JPMorgan Chase & Co filed an 8-K on January 13, 2026 (AccNo: 0001628280-26-001902, Size: 4 MB) reporting financial results under Item 2.02: Results of Operations and Financial Condition and Item 9.01: Financial Statements and Exhibits. This is a multi-item filing for US equity markets via us_sec source. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary.

13-01-2026

SONO TEK CORP filed a Form 8-K on January 13, 2026 (AccNo: 0001171520-26-000002, Size: 372 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This discloses financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned.

13-01-2026

Pelican Acquisition Corp filed an 8-K on January 13, 2026 (AccNo: 0001829126-26-000256, Size: 2 MB) announcing a Merger/Acquisition event via Item 7.01 Regulation FD Disclosure, with Item 9.01 providing Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

DOMO, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001885, Size: 231 KB), reporting entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the agreement, personnel involved, transaction terms, or financial impacts are provided in the summary. Sector is not specified.

13-01-2026

Delta Air Lines, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000027904-26-000008, Size: 2 MB), reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), and financial statements and exhibits (Item 9.01). No specific details on the agreement, transaction value, financial metrics, or other quantitative data are disclosed in the provided filing summary. This is a multi-item mandatory filing under SEC 8-K requirements.

13-01-2026

Energous Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003072, Size: 223 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction values, or quantitative details are disclosed in the provided filing summary. This is a financial results disclosure from the US market.

13-01-2026

uniQure N.V. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003075, Size: 4 MB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific event details, transaction values, or financial metrics provided in the filing summary. All core event information is NOT_DISCLOSED.

13-01-2026

Bausch Health Companies Inc. filed an 8-K on January 13, 2026 (AccNo: 0000885590-26-000005, Size: 147 KB) under Items 2.02 (Results of Operations and Financial Condition) and 7.01 (Regulation FD Disclosure). This reports financial results. No specific financial metrics, transaction details, or quantitative data disclosed in the provided filing summary.

13-01-2026

Kymera Therapeutics, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011104, Size: 188 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

Cardinal Health Inc filed a Form 8-K on January 13, 2026 (AccNo: 0000721371-26-000003, Size: 182 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the core event, transaction, or financial exhibits provided in the summary. No quantitative data, named entities beyond the filer, or material impacts are disclosed.

13-01-2026

Armata Pharmaceuticals, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003076), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or numerical values are disclosed in the filing summary. Sector is not specified.

13-01-2026

Laird Superfood, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001135, Size: 2 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with sector not specified. No core event details, financial metrics, transaction values, or other quantitative data are explicitly stated.

13-01-2026

Palladyne AI Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011108, Size: 495 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item voluntary and mandatory disclosure filing focused on financial results, with no specific numerical financial metrics, transaction values, or detailed outcomes disclosed in the provided summary. Sector not specified.

13-01-2026

Traws Pharma, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003071, Size: 231 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, exhibits, transactions, or quantitative impacts are disclosed in the provided filing summary. All transaction values, financial metrics, and strategic details are NOT_DISCLOSED.

13-01-2026

Sight Sciences, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011106, Size: 216 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results announcement typical for quarterly or annual earnings disclosures. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.

13-01-2026

Soluna Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001945, Size: 344 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is a general filing with sector not specified.

13-01-2026

Concentrix Corp filed an 8-K on January 13, 2026 (AccNo: 0001803599-26-000003, Size: 652 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This is a standard financial results disclosure with no further details available.

13-01-2026

Amneal Pharmaceuticals, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001723128-26-000003, Size: 157 KB), disclosing under Item 2.02 Results of Operations and Financial Condition and Item 7.01 Regulation FD Disclosure. This pertains to financial results in the US market, with sector not specified. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary.

13-01-2026

Actelis Networks Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001213900-26-003681, Size: 237 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or exhibits are disclosed in the provided filing summary. Sector not specified.

13-01-2026

US BANCORP filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011142, Size: 3 MB), reporting under Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific transaction details, dollar values, or financial metrics disclosed. Sector not specified.

13-01-2026

Worksport Ltd filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001956, Size: 242 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with no sector specified. No core event details, financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

Acadia Healthcare Company, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001137, Size: 2 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, revenue, earnings, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Ichor Holdings, Ltd. filed a Form 8-K on January 13, 2026 (AccNo: 0001652535-26-000004, Size: 166 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market. No specific financial metrics, transaction values, or quantitative data are mentioned.

13-01-2026

Trinity Capital Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011144, Size: 301 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the financial statements/exhibits are provided. Sector is not specified.

13-01-2026

Fifth Third Bancorp filed a Form 8-K on January 13, 2026, under Item 8.01 Other Events. Accession Number: 0000035527-26-000011. File size: 752 KB. No details on the specific event, transaction, or financial impacts are disclosed.

13-01-2026

Red Cat Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000748268-26-000003, Size: 157 KB), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard voluntary disclosure of financial results.

13-01-2026

DENTSPLY SIRONA Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000818479-26-000024, Size: 786 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, or reasons are provided.

13-01-2026

Constellation Energy Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001868275-26-000005, Size: 1 MB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, or exhibits are disclosed in the provided filing summary. All transaction details, financial metrics, and quantitative data are NOT_DISCLOSED.

13-01-2026

Lifeward Ltd. filed a Form 8-K on January 13, 2026 (AccNo: 0001178913-26-000132, Size: 2 MB), reporting multiple events including entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), departures/elections/appointments of directors/officers or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No transaction values, share counts, financial metrics, named counterparties, people, or other quantitative details are disclosed in the provided filing summary. This is a multi-item mandatory disclosure.

13-01-2026

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001905, Size: 156 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 7.01 Regulation FD Disclosure. This constitutes financial results disclosure from the US market. No specific revenue, earnings, transaction values, or other numerical metrics are mentioned.

13-01-2026

Pelthos Therapeutics Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001753926-26-000097, Size: 926 KB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a significant transaction likely involving financing or agreements, but no specific details, dollar values, parties, or impacts are disclosed in the provided summary. Sector is not specified.

13-01-2026

Biofrontera Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001959, Size: 294 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or detailed operational results are provided in the filing summary. Sector is not specified.

13-01-2026

Photronics Inc. disclosed an officer change event via Form 8-K filed on January 13, 2026 (AccNo: 0001140361-26-001053, Size: 189 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), appointment/resignation status, reasons, or named individuals are provided in the filing summary. Sector is not specified.

13-01-2026

SS Innovations International, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001213900-26-003688, size: 21 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US SEC. No specific financial metrics, transaction values, or other quantitative details are mentioned.

13-01-2026

Pagaya Technologies Ltd. filed a Form 8-K on January 13, 2026 (AccNo: 0001883085-26-000004, Size: 186 KB) under Item 7.01 for Regulation FD Disclosure. No specific details on the content of the disclosure, transaction, or financial impacts are provided in the filing summary. Sector is not specified.

13-01-2026

TruGolf Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001958, Size: 198 KB) reporting under Item 8.01 Other Events. Sector is not specified. No details on the specific event, transaction values, financial impacts, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

AVITA Medical, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011167), reporting multiple events including entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), results of operations and financial condition (Item 2.02), creation of a direct financial obligation (Item 2.03), and unregistered sales of equity securities (Item 3.02), with exhibits in Item 9.01. This is a multi-item filing with no specific transaction values, financial metrics, or other quantitative details disclosed in the provided summary. Sector is not specified.

13-01-2026

NLIGHT, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001124796-26-000006, Size: 185 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US market with sector not specified. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned in the filing summary.

13-01-2026

Beeline Holdings, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001493152-26-001957, Size: 226 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with sector not specified. No details on the core event, financials, or exhibits are disclosed in the provided summary.

13-01-2026

Expion360 Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001903596-26-000008, Size: 231 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing with no specific details on the core event, transaction, or financial impacts provided. Sector is not specified.

13-01-2026

AudioEye Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003108, Size: 224 KB) reporting Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results disclosure. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.

13-01-2026

IDEXX Laboratories Inc./DE filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003103, Size: 534 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, nature of change (appointment or departure), reasons, or any quantitative data are provided in the summary.

13-01-2026

PureCycle Technologies, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011168, size: 316 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Event Type: General Filing; Sector: not specified.

13-01-2026

Trump Media & Technology Group Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001140361-26-001056, Size: 259 KB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosures, events, transactions, or financial data are provided in the filing summary. Sector not specified.

13-01-2026

Nukkleus Inc. filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003686), disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on deal structure, parties, valuation, or financial impacts are provided in the filing summary. All quantitative metrics, named entities beyond the filer, and strategic rationales are NOT_DISCLOSED.